ArunSinghDOM.S.

Psychiatry • Titusville, NJ

Geriatric Psychiatry, Neuropsychiatry, Clinical Pharmacology

Director, Clinical Leader, Janssen Research & Development

Join to view full profile

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile

Already have an account?

Office
1125 Trenton-Harbourton Rd
Titusville, NJ 08560

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Geriatric Psychiatry, 2009 - 2010
Stony Brook Medicine/University HospitalResidency, Psychiatry, 2005 - 2009
NYIT College Of Osteopathic MedicineClass of 2005

Publications & Presentations

PubMed

3 citations
Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study
Srihari Gopal, Jagadish Gogate, Katalin Pungor, Edward Kim, Arun Singh
Neuropsychiatric Disease and Treatment. 2020-03-06
6 citations
Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Rama Melkote, Arun Singh, An Vermeulen, Bart Remmerie, Adam Savitz
Schizophrenia Research. 2018-11-01
34 citations
Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.
Clifton Blackwood, Panna Sanga, Isaac Nuamah, Alexander Keenan, Arun Singh
Patient Preference and Adherence. 2020-07-02